Scientists consider whether anti-cytokine therapies tocilizumab and anakinra might alleviate disease severity in COVID 19. Tocilizumab (an IL-6 blocker) has been tested with possible benefit. These results have been mixed. Anakinra (an anti-IL-1 medication) as also tested with mixed results. These drugs have been used for …
Tocilizumab and Anakinra for Cytokine Storm
